1,385.68
-19.46 (-1.38%)
| Previous Close | 1,405.14 |
| Volume | 60,475 |
| Price / Earnings (Forward) | 25.91 |
| Price / Sales | 6.69 |
| Price / Book | 2.12 |
| 52 Weeks Range |
| Profit Margin | 22.17% |
| Operating Margin (TTM) | 25.19% |
| Diluted EPS (TTM) | 40.10 |
| Quarterly Revenue Growth (YOY) | -4.60% |
| Quarterly Earnings Growth (YOY) | -7.80% |
| Current Ratio (MRQ) | 1.01 |
| Operating Cash Flow (TTM) | 972.81 M |
| Levered Free Cash Flow (TTM) | 743.66 M |
| Return on Assets (TTM) | 21.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Mettler-Toledo International, I | Mixed | Bullish |
AIStockmoo Score
| Analyst Consensus | NA |
| Insider Activity | 0.0 |
| Price Volatility | -1.0 |
| Technical Moving Averages | 1.0 |
| Technical Oscillators | -0.5 |
| Average | -0.35 |
|
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Core |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 101.90% |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SHUMAN-FABBRI NATALIA | 1,398.58 | - | 16 | 22,377 |
| Aggregate Net Quantity | 16 | |||
| Aggregate Net Value ($) | 22,377 | |||
| Aggregate Avg. Buy ($) | 1,398.58 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SHUMAN-FABBRI NATALIA | Director | 28 Aug 2026 | Acquired (+) | 16 | 1,398.58 | 22,377 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |